LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers

被引：0
|
作者：
Adashek, Jacob J.
Kato, Shumei
Pabla, Sarabjot
Nesline, Mary
Conroy, Jeffrey M.
Subbiah, Vivek
DePietro, Paul
Kurzrock, Razelle
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[3] Omni Seq Inc, Buffalo, NY USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
[5] WIN Consortium, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2561
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
    Arefeh Zabeti Touchaei
    Sogand Vahidi
    Cancer Cell International, 24
  • [22] PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas
    Porcellato, Ilaria
    Mecocci, Samanta
    Brachelente, Chiara
    Cappelli, Katia
    Armando, Federico
    Tognoloni, Alessia
    Chiaradia, Elisabetta
    Stefanetti, Valentina
    Mechelli, Luca
    Pepe, Marco
    Gialletti, Rodolfo
    Passeri, Benedetta
    Ghelardi, Alessandro
    Razzuoli, Elisabetta
    ANIMALS, 2021, 11 (07):
  • [23] PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young Women
    Obeidin, Farres
    Pincus, Jennifer
    Siziopikou, K. P.
    Blanco, Luis
    LABORATORY INVESTIGATION, 2019, 99
  • [24] PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young Women
    Obeidin, Farres
    Pincus, Jennifer
    Siziopikou, K. P.
    Blanco, Luis
    MODERN PATHOLOGY, 2019, 32
  • [25] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
    Saleh, Reem
    Toor, Salman M.
    Khalaf, Sarah
    Elkord, Eyad
    VACCINES, 2019, 7 (04)
  • [26] High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2
    Li, Yanyan
    Liang, Zhaoduan
    Tian, Ye
    Cai, Wenxuan
    Weng, Zhiming
    Chen, Lin
    Zhang, Huanling
    Bao, Yifeng
    Zheng, Hongjun
    Zeng, Sihai
    Bei, Chunhua
    Li, Yi
    CANCER SCIENCE, 2018, 109 (08): : 2435 - 2445
  • [27] Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients
    Kashyap, Seema
    Singh, Mithalesh Kumar
    Kumar, Nikhil
    Jha, Jayanti
    Lomi, Neiwete
    Meel, Rachna
    Bakhshi, Sameer
    Sen, Seema
    Singh, Lata
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (06) : 903 - 912
  • [28] Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses
    Liang, SC
    Latchman, YE
    Buhlmann, JE
    Tomczak, MF
    Horwitz, BH
    Freeman, GJ
    Sharpe, AH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) : 2706 - 2716
  • [29] Expression of PD-1, PD-L1 and PD-L2 within liver of autoimmune liver diseases
    Mataki, Norikazu
    Kikuchi, Kentaro
    Kawai, Toshihim
    Okada, Yoshikiyo
    Kurihara, Chic
    Watanabe, Chikako
    Kohmoto, Shunsuke
    Hokari, Ryota
    Kawaguchi, Atsushi
    Nagao, Shigeaki
    Kondo, Toshiro
    Itoh, Kazuro
    Miyakawa, Hiroshi
    Miura, Soichiro
    GASTROENTEROLOGY, 2006, 130 (04) : A280 - A280
  • [30] PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population
    Karolova, J.
    Radek, M.
    Helman, K.
    Spacek, M.
    Trneny, M.
    Klener, P.
    FOLIA BIOLOGICA, 2020, 66 (04) : 117 - 122
12345